Revlimid 10 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FJU46
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,575
Award facts
- Contract value 100% obligated
- $52,575.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $52,575.49 and an ultimate completion date of September 26, 2025. This is a competitively awarded, non-set-aside delivery order issued to support federal medical procurement needs. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains, particularly supporting the Defense Health Agency and other government healthcare systems. The company's existing federal contract portfolio demonstrates extensive experience delivering a broad range of medications and medical supplies across multiple therapeutic domains. This delivery order for Revlimid, an oncology medication, reflects the company's continued role as a key supplier of specialty pharmaceuticals to support military and federal healthcare operations through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FJU46?
SPE2DB25FJU46 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJU46 worth?
The government has obligated $52,575 on SPE2DB25FJU46.
Is contract SPE2DB25FJU46 an order under another contract?
Yes. SPE2DB25FJU46 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU46 competed?
The extent of competition for SPE2DB25FJU46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award